184 related articles for article (PubMed ID: 33069200)
21. COVID toes or pernio?
Zaladonis A; Huang S; Hsu S
Clin Dermatol; 2020; 38(6):764-767. PubMed ID: 33341212
[TBL] [Abstract][Full Text] [Related]
22. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.
Bascuas-Arribas M; Andina-Martinez D; Añon-Hidalgo J; Alonso-Cadenas JA; Hernandez-Martin A; Lamagrande-Casanova N; Noguero-Morel L; Mateos-Mayo A; Colmenero-Blanco I; Torrelo A
Pediatr Dermatol; 2022 Mar; 39(2):243-249. PubMed ID: 35129855
[TBL] [Abstract][Full Text] [Related]
23. Chilblains in children in the setting of COVID-19 pandemic.
Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A
Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460
[TBL] [Abstract][Full Text] [Related]
24. An Autopsy Review: "COVID Toes".
Yilmaz MM; Szabolcs MJ; Geskin LJ; Niedt GW
Am J Dermatopathol; 2021 Aug; 43(8):554-555. PubMed ID: 33055537
[TBL] [Abstract][Full Text] [Related]
25. Therapy for probable COVID-19 associated erythema pernio-like lesions in pediatric age. Case report.
Ruggiero G; Arcangeli F; Lotti T
Dermatol Ther; 2020 Jul; 33(4):e13616. PubMed ID: 32424851
[No Abstract] [Full Text] [Related]
26. COVID-19 cutaneous manifestations in children and adolescents: a systematic review.
Pasquini Neto R; Mazzo FAT; Vieira FA; Bueno GS; Previdi JVC; Silva LRD; Silva NKBD; Jorizzo JL; Cerci FB
Rev Paul Pediatr; 2022; 40():e2021134. PubMed ID: 35703724
[TBL] [Abstract][Full Text] [Related]
27. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.
Le Cleach L; Dousset L; Assier H; Fourati S; Barbarot S; Boulard C; Bourseau Quetier C; Cambon L; Cazanave C; Colin A; Kostrzewa E; Lesort C; Levy Roy A; Lombart F; Marco-Bonnet J; Monfort JB; Samimi M; Tardieu M; Wolkenstein P; Sbidian E; Beylot-Barry M;
Br J Dermatol; 2020 Nov; 183(5):866-874. PubMed ID: 32628270
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions.
Brancaccio G; Gussetti N; Sasset L; Alaibac M; Tarantello M; Salmaso R; Trevenzoli M; Cattelan AM
Pathog Glob Health; 2021; 115(7-8):483-486. PubMed ID: 33729097
[TBL] [Abstract][Full Text] [Related]
29. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
Kanitakis J; Lesort C; Danset M; Jullien D
J Am Acad Dermatol; 2020 Sep; 83(3):870-875. PubMed ID: 32502585
[TBL] [Abstract][Full Text] [Related]
30. Histopathology of persistent long COVID toe: A case report.
Nirenberg MS; Requena L; Santonja C; Smith GT; McClain SA
J Cutan Pathol; 2022 Sep; 49(9):791-794. PubMed ID: 35366017
[TBL] [Abstract][Full Text] [Related]
31. Perniosis in the COVID-19 era.
Shah I; Stacey SK; Ganne N; Merfeld J
Dermatol Online J; 2021 May; 27(5):. PubMed ID: 34118825
[TBL] [Abstract][Full Text] [Related]
32. No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains.
Docampo-Simón A; Sánchez-Pujol MJ; Gimeno-Gascon A; Palazón-Cabanes JC; Juan-Carpena G; Vergara-De Caso E; González-Villanueva I; Blanes-Martínez M; Betlloch-Mas I
Dermatol Ther; 2020 Nov; 33(6):e14332. PubMed ID: 32975345
[TBL] [Abstract][Full Text] [Related]
33. Pernio in pediatrics.
Simon TD; Soep JB; Hollister JR
Pediatrics; 2005 Sep; 116(3):e472-5. PubMed ID: 16140694
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous Manifestations of SARS-CoV-2 Infection.
Huynh T; Sanchez-Flores X; Yau J; Huang JT
Am J Clin Dermatol; 2022 May; 23(3):277-286. PubMed ID: 35247198
[TBL] [Abstract][Full Text] [Related]
35. Skin manifestations of COVID-19 in children: Part 1.
Andina D; Belloni-Fortina A; Bodemer C; Bonifazi E; Chiriac A; Colmenero I; Diociaiuti A; El-Hachem M; Fertitta L; van Gysel D; Hernández-Martín A; Hubiche T; Luca C; Martos-Cabrera L; Maruani A; Mazzotta F; Akkaya AD; Casals M; Ferrando J; Grimalt R; Grozdev I; Kinsler V; Morren MA; Munisami M; Nanda A; Novoa MP; Ott H; Pasmans S; Salavastru C; Zawar V; Torrelo A;
Clin Exp Dermatol; 2021 Apr; 46(3):444-450. PubMed ID: 33180982
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and management of COVID toes in outpatients: a case report.
Pouxe M; Abdulkarim A; de Vallière S; Seremet T; Favrat B; Kokkinakis I
J Med Case Rep; 2024 Jun; 18(1):307. PubMed ID: 38937799
[TBL] [Abstract][Full Text] [Related]
37. Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 outbreak.
Garcia-Lara G; Linares-González L; Ródenas-Herranz T; Ruiz-Villaverde R
Dermatol Ther; 2020 Sep; 33(5):e13516. PubMed ID: 32378284
[TBL] [Abstract][Full Text] [Related]
38. COVID toes: Pernio-like lesions.
Burke KT; McGinnis KS; Petronic-Rosic V
Clin Dermatol; 2021; 39(3):380-383. PubMed ID: 34517996
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
Nakashima C; Kato M; Otsuka A
J Dermatol; 2023 Mar; 50(3):280-289. PubMed ID: 36636825
[TBL] [Abstract][Full Text] [Related]
40. Cilostazol as a Treatment for COVID Toes: A Case Report.
McClelland P; Gray BH
Ann Vasc Surg; 2023 Apr; 91():76-80. PubMed ID: 36442709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
